EBT Share Purchase

By

Regulatory News | 04 Apr, 2022

Updated : 11:11

RNS Number : 1464H
Frontier Developments PLC
04 April 2022
 

Frontier Developments plc

(the "Company")

 EBT Share Purchase

The Company was notified on 1st April 2022, by Ocorian Limited, the trustee of the Frontier Developments plc Employee Benefit Trust (the "EBT"), that the EBT had purchased 143,855 ordinary shares of 0.5p each in the Company ("Ordinary Shares") at an average price of 1,263 pence per Ordinary Share on 1st April 2022. These Ordinary Shares are to be held in the EBT and are intended to be used to satisfy the exercise of share options by employees. The EBT is a discretionary trust for the benefit of the Company's employees, including the Directors of the Company. The purchase of Ordinary Shares by the EBT has been funded from the Company's existing cash resources.

Following this transaction, a total of 238,757 Ordinary Shares are held by the EBT, representing approximately 0.61 per cent of the Company's total voting rights.

 

Enquiries:

 

Frontier Developments  +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFO 

 

Liberum - Nomad and Joint Broker  +44 (0)20 3100 2000

Neil Patel / Cameron Duncan  

 

Jefferies - Joint Broker  +44 (0)20 7029 8000

Max Jones / William Brown

 

Tulchan Communications  +44 (0)20 7353 4200

Matt Low / Jordan McCulla / Olivia Lucas

 

 

About Frontier Developments plc

Frontier is a leading independent developer and publisher of videogames founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and videogame consoles. As well as self-publishing internally developed games, Frontier also publishes games developed by carefully selected partner studios under its Frontier Foundry games label.

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUPUMUCUPPGUC

Last news